Cipher Pharmaceuticals Inc.

TSX:CPH Stok Raporu

Piyasa değeri: CA$374.9m

Cipher Pharmaceuticals Yönetim

Yönetim kriter kontrolleri 2/4

Cipher Pharmaceuticals CEO'su Craig Mull, Jul2019 tarihinde atandı, in görev süresi 5.33 yıldır. şirketin hisselerinin 3.19% doğrudan sahiptir ve bu hisselerin değeri CA$ 11.97M dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.5 yıl ve 3.5 yıldır.

Anahtar bilgiler

Craig Mull

İcra Kurulu Başkanı

US$1.0m

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi5.3yrs
CEO sahipliği3.2%
Yönetim ortalama görev süresi2.5yrs
Yönetim Kurulu ortalama görev süresi3.5yrs

Son yönetim güncellemeleri

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

CEO

Craig Mull

5.3yrs

Görev süresi

US$1,045,700

Tazminat

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Craig Mull
Interim CEO & Chairman of the Board5.3yrsUS$1.05m3.19%
CA$ 12.0m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 73.3k
Emilio Presti
Director of Sales & Marketing2.8yrsVeri yokVeri yok
Hamed Ghanei
Chief Business Officerless than a yearVeri yokVeri yok

2.5yrs

Ortalama Görev Süresi

Deneyimli Yönetim: CPH 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.5 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Craig Mull
Interim CEO & Chairman of the Board5.7yrsUS$1.05m3.19%
CA$ 12.0m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.43%
CA$ 5.4m
Douglas Deeth
Independent Director1.4yrsUS$65.57kVeri yok
Hubert Walinski
Independent Director1.4yrsUS$62.57kVeri yok

3.5yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: CPH 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.5 yıldır).